Login / Signup

Locomotion behavior testing as a complementary tool in Collembola avoidance assays with neurotoxic insecticides.

Felipe Ogliari BandeiraJéssica Karolayne TinaPaulo Roger Lopes AlvesVitor Pereira VazRodrigo Costa PuerariPhilippe JuneauDavid DewezWilliam Gerson Matias
Published in: Environmental science and pollution research international (2023)
This study aimed (1) to assess the ability of collembolans Folsomia candida to avoid soils contaminated with three seed dressing insecticides imidacloprid, clothianidin, and fipronil; (2) to assess the effects of the insecticides on collembolans' locomotion behavior; (3) to check if changes in the locomotion behavior would explain the avoidance/preference responses; and (4) to evaluate the possibility to use locomotion behavior as toxicity biomarker of the tested insecticides. Avoidance and locomotion behavior assays with collembolans F. candida were performed with commercial seed dressing formulations of three insecticides (imidacloprid, clothianidin, and fipronil). Results showed no avoidance behavior at any concentration, while a "preference" was observed with increasing concentrations of the three tested insecticides. Significant reductions in the locomotion of exposed collembolans were observed at ≥ 1 mg kg -1 for imidacloprid (18-38%) and fipronil (29-58%) and ≥ 4 mg kg -1 for clothianidin (10-47%). At the higher insecticide concentrations, the collembolans had their trajectories restricted to smaller areas, with a tendency for circular movements. Our results confirm that the "preference" for contaminated soils with neurotoxic substances is likely due to locomotion inhibition impairing the ability of organisms to escape. This effect highlights that only avoidance assays may be not sufficient to assure the safety of some substances and confirm the potential of locomotion behavior as a sensitive toxicity biomarker for neurotoxic insecticides.
Keyphrases
  • aedes aegypti
  • heavy metals
  • drinking water
  • high throughput
  • oxidative stress
  • depressive symptoms
  • human health
  • multidrug resistant
  • oxide nanoparticles